within Pharmacolibrary.Drugs.ATC.N;

model N04AB02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.85,
    Cl             = 1.3999999999999998e-05,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.014,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02333333333333333,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N04AB02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Orphenadrine (chloride) is a centrally acting anticholinergic agent used primarily for the symptomatic treatment of Parkinson's disease and drug-induced extrapyramidal symptoms. It is also used as a muscle relaxant. Orphenadrine is still in use today, though newer alternatives exist.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Zhu, LL, et al., &amp; Zhou, Q (2024). Tizanidine: Advances in Pharmacology &amp; Therapeutics and Drug Formulations. <i>Journal of pain research</i> 17 1257–1271. DOI:<a href=\"https://doi.org/10.2147/JPR.S461032\">10.2147/JPR.S461032</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38529017/\">https://pubmed.ncbi.nlm.nih.gov/38529017</a></p></li><li><p>Labout, JJ, et al., &amp; Hespe, W (1982). Difference between single and multiple dose pharmacokinetics of orphenadrine hydrochloride in man. <i>European journal of clinical pharmacology</i> 21(4) 343–350. DOI:<a href=\"https://doi.org/10.1007/BF00637624\">10.1007/BF00637624</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7056281/\">https://pubmed.ncbi.nlm.nih.gov/7056281</a></p></li><li><p>Rutigliano, G, &amp; Labout, JJ (1982). The bioavailability of orphenadrine hydrochloride after intramuscular and oral administration. <i>The Journal of international medical research</i> 10(6) 447–450. DOI:<a href=\"https://doi.org/10.1177/030006058201000612\">10.1177/030006058201000612</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7152086/\">https://pubmed.ncbi.nlm.nih.gov/7152086</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N04AB02;
